Tag: anticoagulation

23-HVI-4469361_atrial-fibrillation_650x450
February 2, 2024/Electrophysiology

Atrial Fibrillation Guideline Introduces Stage-Based Classification, Stresses Early Rhythm Control

ACC/AHA panel also upgrades catheter ablation recommendations

Blood Clot Cell Artery
May 31, 2023/Heart Valve Disease

PROACT Xa: Apixaban Is Not a Safe Warfarin Substitute With Mechanical Aortic Valve

Details released from the trial halted due to excessive thromboembolic events

22-HVI-3285573_LAAC-in-very-old_650x450
December 8, 2022/Geriatrics

Left Atrial Appendage Closure Is Safe to Consider Even in the Very Elderly

Large database analysis finds no rise in in-hospital mortality relative to younger patients

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

20-HVI-1910656-CQD-Tall-Rounds-COVID-Thrombotic-Complications
August 11, 2020/COVID-19

Thrombotic Complications of COVID-19: Principles for Treatment and Prevention

Expert insights and a thromboprophylaxis protocol

20-HRT-019-anticoagulation-650×450
April 7, 2020/Research

PROACT Xa Trial to Assess Non-Warfarin Anticoagulation After AVR With a Mechanical Valve

1,000-patient prospective trial to start enrolling patients soon

19-HRT-5506-anticoagulation-650×450
September 26, 2019/Research

Toward an Evidence-Based Approach to Anticoagulation After Bioprosthetic AVR

PARTNER 2 analysis finds few significant effects

Oussama Wazni, MD
June 18, 2015/News & Insights

LAA Closure Device a Reality: Now What? (Video)

An expert’s take on FDA’s ‘appropriate rationale’ caveat

Bicuspid Aortic Valve Disease
June 11, 2015/News & Insights

Bringing New Thinking to the Treatment of Bicuspid Aortic Valve Disease

‘Lifetime strategy’ entails valve repair — or replacement with a bioprosthesis

BackPage 1 of 1Next
Advertisement
Ad